TollereBio
PrivateCompany Overview
TollereBio is a biotechnology company that develops accessible, cost-effective vaccine adjuvants using its proprietary bacterial enzymatic combinatorial chemistry (BECC) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
vaccine adjuvantTLR4Toll-like receptor 4lipid A mimeticsbiotechnologydrug discoveryvaccine developmentimmunotherapyimmunostimulantbiotech platformBacterial Enzymatic Combinatorial ChemistryBECCvaccine techpreclinical researchbiotech licensing
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TollereBio Comparables
Compare TollereBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inimmune | 81% | |
| Adjuvance Technologies | 80% | |
| Croda International | 71% | |
TollereBio Funding Rounds
Historical fundraising activity
TollereBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TollereBio's valuation, stock price, and market status.